Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $367,659 - $430,828
-14,555 Reduced 10.71%
121,302 $3.39 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $2.94 Million - $3.38 Million
113,700 Added 513.16%
135,857 $3.77 Million
Q4 2023

Jan 12, 2024

SELL
$26.13 - $33.94 $49,333 - $64,078
-1,888 Reduced 7.85%
22,157 $637,000
Q3 2023

Nov 01, 2023

SELL
$32.09 - $37.51 $2.91 Million - $3.4 Million
-90,769 Reduced 79.06%
24,045 $797,000
Q2 2023

Jul 12, 2023

BUY
$36.12 - $41.79 $1.58 Million - $1.83 Million
43,683 Added 61.41%
114,814 $4.21 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $2.25 Million - $2.92 Million
57,028 Added 404.37%
71,131 $2.9 Million
Q4 2022

Jan 25, 2023

SELL
$41.75 - $54.5 $8,642 - $11,281
-207 Reduced 1.45%
14,103 $0
Q3 2022

Oct 19, 2022

SELL
$43.76 - $53.42 $789,780 - $964,124
-18,048 Reduced 55.78%
14,310 $626,000
Q2 2022

Jul 27, 2022

SELL
$46.53 - $55.17 $46,576 - $55,225
-1,001 Reduced 3.0%
32,358 $1.7 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $774,593 - $959,818
-16,931 Reduced 33.67%
33,359 $1.73 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $111,605 - $165,436
2,701 Added 5.68%
50,290 $2.97 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $1,687 - $2,168
43 Added 0.09%
47,589 $2.05 Million
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $54,583 - $61,833
1,520 Added 3.3%
47,546 $1.86 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $528,505 - $596,048
15,781 Added 52.18%
46,026 $1.67 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $1.01 Million - $1.29 Million
30,245 New
30,245 $1.11 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Heron Bay Capital Management Portfolio

Follow Heron Bay Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heron Bay Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Heron Bay Capital Management with notifications on news.